A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

PURPOSE: Preclinical data suggest that radiotherapy (RT) is beneficial in combination with immune checkpoint blockade. Clinical trials have explored RT with single-agent immune checkpoint blockade, but no trials have reported RT with the combination of nivolumab and ipilimumab. PATIENTS AND METHODS:...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Postow, Michael A., Knox, Susan J., Goldman, Debra A., Elhanati, Yuval, Mavinkurve, Vikram, Wong, Phillip, Halpenny, Darragh, Reddy, Sunil K., Vado, Kenya, McCabe, Danielle, Aufiero Ramirez, Kristen, Macri, Mary, Schwarzenberger, Paul, Ricciardi, Toni, Ryan, Aileen, Venhaus, Ralph, Momtaz, Parisa, Shoushtari, Alexander N., Callahan, Margaret K., Chapman, Paul B., Wolchok, Jedd D., Subrahmanyam, Priyanka B., Maecker, Holden T., Panageas, Katherine S., Barker, Christopher A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7959513/
https://ncbi.nlm.nih.gov/pubmed/32205463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3936
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller